Emergent BioSolutions (EBS) Change in Account Payables (2010 - 2026)
Emergent BioSolutions (EBS) posted Change in Account Payables of $10.0 million for Q2 2026, up 169.44% on a QoQ basis from -$14.4 million in Q1 2026, and up 196.15% year-over-year from $3.4 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Change in Account Payables (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Change in Account Payables for 17 years, with the latest figure at $10.0 million in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 196.15% year-over-year to $10.0 million in Q2 2026; TTM through Jun 2026 was $3.0 million, a 106.12% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, up 74.55% from the prior year.
- Change in Account Payables was $10.0 million for Q2 2026 at Emergent BioSolutions, up from -$14.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $31.0 million in Q1 2023, with the low at -$23.0 million in Q3 2024.
- Average Change in Account Payables over 5 years is -$2.7 million, with a median of -$4.1 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables soared 310.88% in 2023, then sank 500.0% in 2025.
- Over 5 years, Change in Account Payables stood at -$2.2 million in 2022, then slumped by 222.73% to -$7.1 million in 2023, then sank by 43.66% to -$10.2 million in 2024, then jumped by 211.76% to $11.4 million in 2025, then retreated by 12.28% to $10.0 million in 2026.
- The last three Change in Account Payables figures came in at $10.0 million (Q2 2026), -$14.4 million (Q1 2026), and $11.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | - |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | -29.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | - |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 37.53 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 5.03 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.00 Mn |
| Mar 31, 2026 | -14.40 Mn |
| Dec 31, 2025 | 11.40 Mn |
| Sep 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -10.40 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Dec 31, 2024 | -10.20 Mn |
| Sep 30, 2024 | -23.00 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Dec 31, 2023 | -7.10 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Jun 30, 2023 | -20.10 Mn |
| Mar 31, 2023 | 31.00 Mn |
| Dec 31, 2022 | -2.20 Mn |
| Sep 30, 2022 | -4.20 Mn |
| Jun 30, 2022 | 7.10 Mn |
| Mar 31, 2022 | -14.70 Mn |
| Dec 31, 2021 | -5.10 Mn |
| Sep 30, 2021 | -4.50 Mn |
API Access
Emergent BioSolutions Change in Account Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-account-payables", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();